Poolbeg secures free supply of bispecific antibody for POLB 001 trial at The Christie

Poolbeg receives FDA Orphan Drug Designation for POLB 001

Poolbeg Pharma
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.